Cargando...
Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity
BACKGROUND: Bortezomib, a specific and selective inhibitor of the 26S proteasome with antitumor activity against a wide range of malignancies, has been approved for the treatment of relapsed or refractory multiple myeloma and other cancers. Recently, bortezomib has been identified as an effective in...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2442611/ https://ncbi.nlm.nih.gov/pubmed/18534018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-7-50 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|